| Financial Year |
March 31 2023 |
| Monetary Funds |
335,171,224.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
51,654,234.46 |
| Accounts Receivable |
181,439,789.32 |
| Advances to Suppliers |
4,442,152.85 |
| Other Receivables |
2,195,793.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
162,813,123.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,783,534.01 |
| Other Current Assets |
243,992,454.08 |
| Total Current Assets |
1,032,024,147.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,393,765.12 |
| Investment Properties |
42,054,632.08 |
| Fixed Assetes |
709,056,280.25 |
| Under-construction Projects |
30,600,917.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,960,430.04 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,624,218.33 |
| Deferred Income Tax Assets |
28,538,143.93 |
| Other Non-Current Assets |
216,569,169.15 |
| Sub-Total of Non-Current Assets |
1,083,812,189.01 |
| Total Assets |
2,115,836,336.04 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
82,979,792.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,742,326.83 |
| Taxes Payable |
21,703,112.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,107,689.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,758,869.17 |
| Other Current Liabilities |
15,793,467.48 |
| Sub-Total of Current Liabilities |
174,124,844.71 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
100,729,288.45 |
| Total Liabilities |
274,854,133.16 |
| Paid-In Capital(Or Share Stock) |
278,102,394.00 |
| Capital Surplus |
974,020,681.50 |
| Surplus Reserve |
57,077,333.81 |
| LESS:Treasury Stock |
15,007,209.00 |
| Undistributed Profits |
530,109,020.66 |
| Minority Stockholder's Interest |
16,679,981.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,824,302,220.97 |
| Owner's Equity（Stockholder's Equity） |
1,840,982,202.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,115,836,336.04 |
